UBS’ Top Tech Based Disruptive Stocks For 2030: Top 29 Stocks

14. IQVIA Holdings Inc. (NYSE:IQV)

Number of Hedge Fund Holders In Q2 2024: 59

IQVIA Holdings Inc. (NYSE:IQV) is a software and project management company that caters to the needs of the healthcare industry. This places it right at the epicenter of the potential of artificial intelligence to disrupt healthcare especially when it comes to developing new drugs. As of H1 2024, 55% of IQVIA Holdings Inc. (NYSE:IQV)’s revenue came from its research and development business, essentially flat year over year. This was because research spending at pharma companies slows down when interest rates are high. Revenue growth for IQVIA Holdings Inc. (NYSE:IQV)’s technology business and contract business was also muted. Crucially though, this wasn’t due to any fundamental weakness for the firm; instead, it reflected a slowdown in the broader industry. Consequently, as healthcare spending picks up, IQVIA Holdings Inc. (NYSE:IQV) could see tailwinds.

Oakmark Capital mentioned IQVIA Holdings Inc. (NYSE:IQV) in its Q2 2024 investor letter. Here is what the fund said:

“IQVIA Holdings was the top detractor during the quarter. Although the U.S.-based health care com- pany’s stock price fell following the release of first quarter results, the company’s fundamentals were in-line with consensus expectations. Forward-look- ing indicators in the clinical trial business continue to be favorable, and management foresees gradual improvement in the technology and analytics solu- tions segment in the second half of this year and a stronger rebound next year. We believe IQVIA should sustain above-average long-term growth even though it trades at a discount to other life sci- ences and data/information services companies.”